SomaDetect
$20.0K
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
SomaDetect is currently valued at N/A as of December 13, 2024. The company has raised a total of $19.0M in funding.
Investment Perspective
SomaDetect's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is SomaDetect Worth in 2025?
As of 2025, SomaDetect is valued at N/A, based on the company's Accelerator/Incubator funding round in December 13, 2024. This valuation positions SomaDetect as one of the leading private companies in the sector.
SomaDetect Valuation History
SomaDetect's funding history demonstrates steady growth and investor confidence.
How SomaDetect Valuation is Determined
Private company valuations like SomaDetect's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
SomaDetect Valuation FAQs
Is SomaDetect profitable?
SomaDetect has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does SomaDetect's valuation compare to competitors?
SomaDetect is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will SomaDetect IPO?
SomaDetect has not announced plans for an initial public offering. Until an IPO, investors can access SomaDetect shares through secondary market platforms.